Clinical Trial 54654

Scottsdale, AZ 85260


Study Summary:

Title: RSV and Influenza Vaccine for Adults ≥65 Years

Objective: This study aims to assess the safety, tolerability, and immune response of the Respiratory Syncytial Virus (RSV) vaccine, designed to protect against RSV, when administered alongside a high-dose, quadrivalent seasonal influenza vaccine. The study focuses on adults aged 65 years and older.

Why Participate:

  • Contribute to Science: By participating, you'll contribute to the development of a new vaccine that could help protect older adults against RSV.
  • Safety and Tolerability: The study assesses the safety and how well the vaccines are tolerated.
  • Age Group: If you're 65 years or older, this study is specifically designed for your age group.

What to Expect:

  • Vaccination: You'll receive both the RSV vaccine and a high-dose seasonal influenza vaccine.
  • Observation: The study is observer-blind, meaning some participants may receive a placebo, while others receive the vaccines.
  • Monitoring: You'll be closely monitored throughout the study to track your immune response and any potential side effects.

Qualified Participants Must:

• Be at least 65 years of age
• No vaccinations of any kind within the last 28 days
• No flu vaccine within the last 6 months
• Never had a vaccine for RSV

Qualified Participants May Receive:

  • Compensation for time and travel
  • Free RSV and Flu vaccines
  • Free study-related lab work

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.